Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...
Overcoming the known power and size limitations in LiDAR design is critical to enabling scalable, cost-effective adoption ...
The Dow Jones gained nearly 500 points to close above the record 49,000 mark for the first time. The index has gained nearly ...
The coldest air will be short-lived. By midweek, most of Florida is expected to be back to a more normal winter weather ...
With FOMO rising among retail investors, the real question now is not whether to invest, but how much and where to invest in ...
A district-led initiative by Healthnovo is now changing that. Over the last 12-15 months, Healthnovo’s portable NovoATMs have been deployed across tribal schools and community camps in Palghar, which ...
Nvidia’s long-awaited G-Sync Pulsar promises motion as smooth as what you'd get from a 1,000Hz display—if one existed! It's ...
Sports reporter Curt Conrad embarked on a year-long wellness journey in 2025. He shares his thoughts about that journey ...
New data science-driven alert framework expected to reduce clinician burden by 45% while preserving industry-leading ...
First-home buyers and investors are charging into 2026 at full tilt with a competitive start to the selling season.
Blue Owl Capital offers a high but safe dividend yield and is currently undervalued after recent underperformance and ...
Monthly CPI cools; shares extend gains; 3D Energi soars 13pc; 4D Medical and West African hit record highs; $A at 14-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results